Intravenous administration of desoxycorticosterone glucoside (DCG) in man has been reported to cause an immediate liberation of sugar from the brain into cerebral venous blood (1). It is said that a portion of this reducing substance may be galactose rather than glucose as it is non-fermentable (1). The finding in the fasting state of blood glucose levels higher in blood draining an organ than in the blood entering it is unusual except in the liver. As the reported findings postulated a new physiological concept, an attempt was made to confirm these studies.
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In the original report, the rise in sugar concentration in internal jugular blood was found after the injection of DCG and during the period of inhalation of 15 per cent N20. As these procedures were reported not to cause a change in cerebral blood flow or cerebral oxygen consumption (1), only measurements of blood sugar content were made following 1) intravenous DCG and 2) inhalation of 15 per cent and 50 per cent N20.
METHOD
Seven physically normal subj ects were studied in the fasting state. Blood specimens were obtained from the femoral artery and from the internal jugular vein (2) . After control specimens were taken, DCG 3 (50 mg. in 5 cc. water containing 10% glucose and 10% acetamide) was given intravenously into an antecubital vein over a time period of one minute. Simultaneously drawn arterial and cerebral venous blood samples were taken at frequent intervals from one to fifteen minutes after injection.
All blood sugar determinations were done in duplicate, -using Nelson's (3) modification of the Somogyi method for measuring blood glucose. 1 This investigation was supported, in part, by a research grant from the National Institutes of Health, U. S. Public Health Service. 2 American Heart Association Fellow. Present address: Ohio State University, Columbus, Ohio. 3 The desoxycorticosterone glucoside used in this study was generously supplied by the Ciba Pharmaceutical Products, Inc., Summit, New Jersey.
RESULTS
In Table I are given the simultaneous arterialcerebral venous sugar differences in six subjects after intravenous administration of 50 mg. of DCG. No change in A-V difference or in blood sugar level occurred. Table II shows the effect of 15 per cent and 50 per cent N20 on blood sugar levels and on arterial-cerebral venous sugar difference. The results are those obtained on one subject after inhalation of 15 per cent N20 over a period of 10 minutes and, after inhalation of 50 per cent N20 over a second 10-minute period. The patient noted slight drowsiness with the second procedure but no other symptoms. DISCUSSION DCG, in the dosage used, did not significantly change blood sugar levels or arterial-cerebral venous blood sugar difference. The slight immediate, but brief, increase in both arterial and cerebral 
